CONMED Corporation Announces Fourth Quarter and Fiscal Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- S&P Global explores potential separation of Capital IQ business
Leerink Partners Remains Bullish as Conmed's (CNMD) Growth Acceleration Shows Evolving Turnaround
January 28, 2016 10:10 AM ESTLeerink Partners reiterated an Outperform rating on CONMED (NASDAQ: CNMD), and cut the price target to $50.00 (from $51.00), following the company's 4Q report. Results were marked by solid growth acceleration in ortho and in Leerink's view, the Surgiquest acquisition should be an important catalyst for the... More
Conmed (CNMD) Tops Q4 EPS by 1c; Guides
January 27, 2016 4:24 PM ESTConmed (NASDAQ: CNMD) reported Q4 EPS of $0.52, $0.01 better than the analyst estimate of $0.51. Revenue for the quarter came in at $191 million versus the consensus estimate of $191.03 million.
GUIDANCE:
Conmed sees FY2016 EPS of $1.85-$1.95, versus the consensus of $1.80. Conmed sees FY2016... More



